| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.42 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |